A private, screened luncheon for regional and international investors seeking syndicate partners.
RESI Boston | Wednesday, September 23 | 75 Seats
|
RSVP for Cross-Border Investor Luncheon Today |
By Dennis Ford, Founder & CEO, Life Science Nation (LSN)
Nearly nine out of ten life science startups fail. Not because the science is poor, but because they never connect to the right capital and strategic partners. Solving that is the reason Life Science Nation exists, and for more than fifteen years our work has come down to one thing: finding parties who need each other and matching them.
As some readers know, LSN has been addressing this pervasive dilemma through the LSN Labs Anchor Node Program. An Anchor Node combines LSN’s commercialization methodology and global capital formation network with a regional partner’s laboratories, entrepreneurial programs, and operating platform to produce investment-ready life science companies.
As we expanded the Anchor Node Program across Boston, Australia, Japan, Korea, the UK, and Brazil, a clear pattern emerged: regional partners constantly brought their local VCs to the table seeking international capital. At the same time, our own data across five global RESI events revealed that twenty percent of all partnering meetings were already investor-to-investor.
So we decided to formalize it, and provide a dedicated room for these partners to connect.
The Cross-Border Investor Luncheon, CBIL, is a private luncheon at RESI Boston for regional and international investors seeking syndicate partners. Regional investors have access to exceptional companies that often never reach international investors. International investors have access and reach that regional funds cannot build alone. Both are looking for the same thing across Asia, Europe, North America, and South America.
Attendance is screened. CBIL is for active investors seeking syndicate partners outside their own region, whether that means bringing international capital into local deals or gaining access to deal flow in regions where they have no presence.
Taking place on Wednesday, September 23, CBIL follows the format of the Global Family Office BioForum luncheon (GFOB luncheon takes place on Tuesday, September 22), now in its eighth year. Across those eight years, GFOB has brought family offices together to find each other, form alliances, and build syndicates. CBIL is the natural next step, applying the same private, curated format to the international investor community.
“The future of life science investing is not just finding great companies. It is finding great syndicate partners in the global arena.”
Dennis Ford, Founder and CEO, Life Science Nation
Wednesday, September 23 | Private luncheon | Screened RSVP | 75 seats
Every RSVP is reviewed. Request your seat today!
|
RSVP for Cross-Border Investor Luncheon Today |
Prepare for RESI Boston: Join Our Pre Conference Webinar Series
By Karen Deyo, VP of Product, Israel BD, LSN
Success at RESI Boston begins long before the conference starts. In the weeks leading up to the event, Life Science Nation is hosting a series of complimentary educational webinars designed to help innovators strengthen every aspect of their fundraising journey. From refining your messaging and marketing collateral to learning about emerging technologies, preparing your investor pitch, and navigating the RESI partnering system, these sessions will help you arrive at RESI Boston ready to maximize every opportunity.
Whether you are preparing for investor meetings, applying to the Innovator’s Pitch Challenge, or looking to sharpen your fundraising strategy, these webinars provide practical insights you can immediately put into action.
Branding and Messaging from Seed to Series B: Building Marketing Collateral That Attracts Investors
Monday, August 3 | 11:00 AM ET
Your marketing collateral is often the first impression investors have of your company. This interactive workshop explores how to build a compelling and consistent investment story across your tagline, elevator pitch, executive summary, one page tear sheet, and pitch deck.
Attendees will learn how to effectively communicate the three pillars’ investors evaluate: your technology, your market opportunity, and your business strategy while tailoring messaging for different audiences and strengthening materials through investor feedback.
Register: https://go.lifesciencenation.com/osolca
RESI Boston Partnering Tutorial
Tuesday, August 18 | 11:00 AM ET
The RESI partnering system is one of the most valuable tools available to attendees, but maximizing its potential requires the right strategy. Join the Life Science Nation team for a walkthrough of the partnering platform, including how to identify the best fit investors and strategic partners, manage outreach effectively, develop a successful meeting request strategy, follow up with purpose, and leverage RESI content to maximize your conference experience.
Registration: https://go.lifesciencenation.com/q5QmbZ
Educational Webinars Hosted by RESI Boston Sponsors
In addition to Life Science Nation’s educational workshops, RESI Boston sponsors are offering complimentary webinars that showcase their expertise and provide valuable insights for the life science community.
Biocytogen Webinar
RenSuper Workstation: An AI Driven Antibody Discovery Platform From Target to Antibody Leads in Click
Wednesday, August 26 | 1:00 PM ET
Discover how Biocytogen’s AI driven RenSuper Workstation integrates immunization, next generation sequencing, AI powered high throughput screening, and experimental validation to accelerate antibody discovery and deliver development ready antibody candidates.
Register: https://go.lifesciencenation.com/tooA7s
RSM Webinar – Life Sciences Strategic Managed Services Leader
RSM, a global consulting, tax, and assurance firm with deep expertise serving the life sciences industry, will host a complimentary webinar focused on helping emerging companies navigate growth, fundraising, and commercialization.
Tuesday, September 1 | 12:00 PM ET
Join RESI Boston sponsor RSM for a complimentary webinar featuring insights and expertise for life science companies preparing to grow, raise capital, and navigate today’s evolving business landscape.
Register: https://go.lifesciencenation.com/deHMNq
Maximizing the Power of Your Pitch
Thursday, September 17 | 11:00 AM ET
Just days before RESI Boston begins, this workshop will help innovators prepare one of the most important moments of fundraising: the investor pitch.
Learn practical techniques for crafting a compelling presentation, navigating the application process, delivering an engaging pitch, and confidently handling investor led questions and answers. Whether you are participating in the Innovator’s Pitch Challenge or meeting investors one on one, this session will help you present your company with confidence.
Register: https://go.lifesciencenation.com/akrBbw
Together, these webinars provide a comprehensive roadmap for RESI Boston preparation. From developing a compelling investment story and learning from industry experts to mastering the partnering platform and delivering a winning pitch, each session is designed to help you maximize every investor interaction before the conference begins.
Register for the webinars that best fit your fundraising needs and arrive at RESI Boston fully prepared to connect with investors, strategic partners, and industry leaders.
Finding the Right Investors Starts with the Right Data
By Max Braht, VP of Business Development, LSN
For early-stage life science companies, fundraising success depends on connecting with investors who are actively looking for technologies like yours. That is why Life Science Nation (LSN) has spent years building one of the industry’s most comprehensive investor databases, designed specifically to help innovators identify the right capital partners.
Unlike generic databases built through web scraping, the LSN Investor Database is curated directly through 1:1 interviews with investors and strategic in-licensors, providing startups with insights that go far beyond basic contact information or what you find on an investor’s website. Each investor profile includes valuable details such as typical check size, preferred modalities and indications, stage of development, geographic focus, and more, allowing companies to build a highly targeted fundraising strategy.
The database includes more than 4,000 global investment firms across 10 distinct investor categories and over 12,000 investor contacts spanning therapeutics, medical devices, diagnostics, digital health, and other life science sectors. Whether you are raising a Seed, Series A, or Series B round, identifying investors who are an actual fit can save significant time and improve the quality of your outreach.
Not sure where to begin? Life Science Nation is offering a complimentary investor search to help companies uncover potential investors that may not already be on their radar. The search demonstrates how the LSN Investor Database can provide each company with a curated list of investors matched to their technology and stage of development, along with contact information to then go out and execute on a fundraising campaign.
LSN is also happy to offer a free Fundraising Readiness Assessment through our internally developed AI Agent. The assessment will generate a 6-page report that can be used to help transition your companies’ story from an “interesting technology” into a compelling and ultimately investable company.
Book your free investor search today or complete the AI assessment to take the first step toward building a more focused and effective fundraising campaign.
| Book Your Free Investor Search Today |
RESI Boston 2026 Agenda Announced: Two Days of Investor Insights, Partnership Strategy, and Networking
By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
The agenda for RESI Boston 2026 is here, offering attendees an in-depth look at the conversations shaping the future of early-stage life science investment. Taking place September 22–23 at The Westin Copley Place in Boston, followed by virtual partnering days on September 25, 28, and 29, the expanded two-day in-person conference delivers more opportunities than ever to connect with investors, strategic partners, and industry leaders.
This year’s program reflects the evolving priorities of the healthcare investment ecosystem, with sessions designed to help innovators better understand today’s fundraising environment while building the relationships needed to move their companies forward.
Day one begins by exploring why Boston remains one of the world’s premier biotechnology hubs before examining key topics including partnering with health systems, how venture investors evaluate early-stage therapeutics, securing pharmaceutical partnerships, corporate venture capital strategies, digital health innovation, and the growing influence of family offices in healthcare investing. The day also features the Global Family Office Bioforum (GFOB), an invite-only private networking lunch that brings together select family office investors for high-value discussions and relationship building.
On day two, programming shifts toward emerging investment trends with sessions highlighting angel investing, women’s health, impact investing, and the increasingly important role of mission-driven capital. The conference concludes with two Reverse VC Pitch sessions, where investors take the stage to present directly to entrepreneurs, providing attendees with valuable insight into investment priorities, fund strategies, and what investors are actively seeking in new opportunities. The day also features the exclusive Global VC Connect Lunch, creating another dedicated opportunity for venture capital investors to build meaningful connections.
As always, RESI programming is designed to provide practical insights rather than theory. Whether attendees are preparing for their next fundraising round, pursuing strategic partnerships, or looking to better understand today’s investment landscape, every panel is curated to deliver actionable perspectives from experienced investors and industry leaders.
Combined with RESI’s partnering platform and three additional days of virtual meetings, the conference offers a comprehensive environment for companies seeking to advance fundraising and business development efforts.
Join the RESI Speaker Lineup
Are you an investor or strategic partner with valuable insights to share with early-stage life science companies? We are looking for dynamic speakers to join our RESI panels. Click here to submit your Speaker Interest Form today!
Registration is now open, with super early bird pricing currently available. Companies planning to attend are encouraged to register early to secure the best available rates and begin preparing for one of the most anticipated life science investment events of the year.
Register today and join the global life science investment community at RESI Boston 2026.
| Register for RESI Boston |
Registration Now Open for RESI JPM 2027
By Max Braht, VP of Business Development, LSN
Life Science Nation is excited to announce that registration is now open for RESI JPM 2027, taking place January 11–12 at the San Francisco Marriott Marquis, followed by three days of virtual partnering on January 13, 18, and 19.
Held alongside the world’s largest gathering of healthcare investors, executives, and innovators during JPM Week, RESI JPM provides early-stage life science companies with a unique opportunity to raise capital, build strategic partnerships, and accelerate business development in one of the industry’s most active networking environments.
Previous RESI JPM conferences welcomed more than 1,000 attendees, including over 600 active investors, strategic partners, pharmaceutical business development professionals, and industry leaders. The conference combines curated educational programming with one-on-one partnering meetings, creating meaningful opportunities for fundraising companies to connect directly with the investors and partners best aligned with their technologies.
The expanded format begins with two full days of in-person programming at the San Francisco Marriott Marquis, featuring investor panels, educational workshops, the Innovator’s Pitch Challenge, networking events, poster presentations, and partnering meetings. The conference then continues online with three additional days of virtual partnering, allowing participants to maximize the number of meetings they can schedule while extending networking opportunities beyond the in-person event.
Whether you are seeking Seed, Series A, or Series B financing, exploring strategic partnerships, licensing opportunities, or looking to expand your visibility within the life science investment community, RESI JPM offers multiple ways to engage. Registration options are available for startups, fundraising executives, service providers, technology hubs, exhibitors, and qualified investors.
Early Bird registration is now available, offering substantial savings on five-day hybrid registration for startups and fundraising executives. Register early to lock in the lowest available rates.
Organizations looking to maximize their visibility during JPM Week can also take advantage of sponsorship and exhibition opportunities designed to connect brands with a highly targeted audience of investors, innovators, and industry leaders.
Register today and save up to $900 with Super Early Bird pricing!
| Register Now |
Don’t miss your opportunity to be part of one of the life science industry’s premier fundraising and partnering events.
RESI San Diego Innovator’s Pitch Challenge Winners Showcase the Future of Life Science Innovation
By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
The Innovator’s Pitch Challenge (IPC) returned to RESI San Diego 2026, bringing together some of the most promising early-stage life science companies for one of the conference’s signature events. Designed to connect early-stage innovators with active investors and strategic partners, the IPC provides a platform for companies to showcase breakthrough technologies while gaining valuable exposure and feedback.
Each finalist delivered a six-minute presentation followed by a live Q&A with an investor judging panel. Throughout the conference, participants also met with investors during one-on-one partnering meetings and networking sessions, extending conversations well beyond the pitch stage.
The IPC winners are determined through a combination of investor judge evaluations and RESI Cash voting. Judges evaluate each company based on the strength of its technology, investment opportunity, presentation, and responses during Q&A, while attendees allocate RESI Cash to the companies they believe demonstrate the greatest investment potential. Together, these scores recognize companies that impressed both the judging panel and the broader RESI community.
Congratulations to the overall winners of the RESI San Diego 2026 Innovator’s Pitch Challenge:
1st Place: Nanotrace
Nanotrace combined the best attributes of chemotherapy, nanoparticle delivery mechanisms, and the latest advancements in gene therapeutics to build a revolutionary oncology platform. Based on our team’s decades of research in these fields, and the maturation of nanomedicine, our product is a novel targeting platform which recognizes cancer cells by its very blueprint – gene expression. In part by using AI, that highly specific recognition is programmed to release a chemotherapeutic payload inside a cancer cell while leaving healthy cells unaffected. Our platform will transform how we treat not only cancer but a whole spectrum of genetic disorders. Nanotrace is founded by Dr. Will Briley, PhD Molecular Biology from Northwestern; Dr. Paul Weiss, renowned nanoscientist, distinguished UCLA professor, and a UC Presidential Chair; David Spector, an experienced founder and formerly of Sequoia Capital, Google, and MIT; and, Chief Medical Advisor, Dr. Krishna Komanduri, Department Chief & Head of Hematology & Oncology, UCSF.
2nd Place: Pinion Immunotherapeutics
Pinion Immunotherapeutics is a Maryland-based biotechnology company focused on developing novel immunotherapies for chronic viral infections and virus-driven cancers. Its proprietary AI-driven mRNA platform generates immunotherapies targeting HPV-related precancer, AML, EBV, and HSV, designed to activate CD8⁺ T cells while inducing virus-neutralizing antibodies to achieve durable immune control. Pinion operates as a lean, high-impact virtual company, deploying capital directly to science and clinical trials, not overhead. Our leadership team brings deep expertise across mRNA platform development, FDA regulatory strategy, clinical trial design, and immunology. Our programs target indications with large addressable populations, no curative standard of care, and high economic burden, where mRNA immunotherapy offers a genuine path to functional cure.
3rd Place: FELIQS
Feliqs is a clinical-stage ophthalmology company developing innovative therapies for retinal and corneal diseases with significant unmet medical needs. The company is advancing a diversified pipeline targeting conditions including retinopathy of prematurity (ROP), pterygium, and dry age-related macular degeneration (Dry AMD), addressing diseases that currently have limited or no effective treatment options. Leveraging novel mechanisms targeting oxidative stress, fibrosis, and angiogenesis, FELIQS is developing patient-friendly therapies designed to reduce dependence on invasive procedures while improving long-term visual outcomes. Through its innovative ophthalmology pipeline, FELIQS aims to preserve vision, prevent blindness, and improve quality of life for patients worldwide.
In addition to the overall winners, several companies earned the highest combined judge and RESI Cash scores within their individual pitch sessions. Congratulations to these outstanding innovators for delivering exceptional presentations and capturing investor interest throughout the competition.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Every company that participated in the Innovator’s Pitch Challenge demonstrated the innovation, passion, and entrepreneurial spirit that continue to define the RESI community. Congratulations to all of this year’s participants.
Will Your Company Be Next?
Applications are now open for the RESI Boston Innovator’s Pitch Challenge, taking place during the expanded two-day, in-person RESI Boston conference this September during Biotech Week Boston.
The IPC is more than a pitch competition. It is an opportunity to present your company to active investors, receive expert feedback, gain additional visibility through poster presentations and partnering meetings, and compete for recognition among the global life science investment community.
Whether you’re preparing for your next financing round or looking to build strategic partnerships, the Innovator’s Pitch Challenge can help elevate your fundraising efforts.
Applications are now open. Apply today and take the stage at RESI Boston.
| Apply to Pitch at RESI Boston |
Build Your Brand at the Expanded Two-Day RESI Boston
By Max Braht, VP of Business Development, LSN
Following the success of RESI San Diego, sponsorship opportunities are now available for RESI Boston, taking place September 22–23 during Biotech Week Boston. With two days of in-person programming, followed by three days of virtual partnering, RESI Boston offers even more opportunities to connect with the global life science investment community.
RESI San Diego welcomed an outstanding group of sponsors representing every corner of the life science ecosystem. Title Sponsors included Innopolis Jeonbuk Innovation Cluster, Biometas, and Korea Bio Innovation Center (KBIC). Gold Sponsors RSM and Medmarc shared their expertise through thought leadership and networking, while Silver Sponsors Biocytogen, Foley Hoag, and Polsinelli connected with innovators and investors throughout the conference. Additional support from Bronze Sponsors BSR Korea, JABI, Jeongup Si, Jeonbuk State, the Ministry of Science and ICT (Korea), Alithia Life Sciences, and Inertia further strengthened the event’s international reach.
Sponsoring RESI is more than displaying your logo. Sponsors gain visibility before, during, and after the conference through digital marketing, onsite branding, exhibit opportunities, educational programming, and access to RESI’s partnering platform. Whether your organization is looking to generate business leads, recruit new clients, showcase a regional innovation ecosystem, or establish thought leadership, RESI provides direct access to founders, investors, strategic partners, and service providers actively shaping the future of life sciences.
The expanded two-day in-person format at RESI Boston means more networking, more meetings, more educational sessions, and more opportunities for meaningful engagement than ever before. Combined with virtual partnering that continues after the event, sponsors benefit from sustained visibility and valuable follow-up opportunities well beyond the conference itself.
Ready to elevate your brand at RESI Boston? Explore the full range of sponsorship opportunities by downloading the RESI Sponsorship Brochure, or visit the RESI Sponsors page to learn more. To discuss a customized sponsorship package that aligns with your business development goals, contact sales@lifesciencenation.com. Sponsorship packages can be tailored to maximize your visibility, thought leadership, and connections within the global life science investment community.
Next Phase Newsletter 